Properties
What is it?
International Name - Trypsin+Chymotrypsin Active proteolytic enzymes: Trypsin - 100,000 SE Chymotrypsin - 21,000 SE Proteolytic enzymes: trypsin and chymotrypsin, in enteric-coated tablets. Chymoral has a specific catalytic effect on endopeptidases and esterases. Upon entering the circulatory system, the enzymatic action of trypsin and chymotrypsin is inhibited. Due to reversible inhibition, trypsin and chymotrypsin regain their enzymatic activity when they enter an open wound or open, damaged blood vessels from the circulatory system. Thus, released trypsin and chymotrypsin exhibit their proteolytic, anti-edema, and anti-inflammatory effects. Chymoral enteric-coated tablets Recommendations for use: - Swelling and hematomas - Reduced blood flow and lymphatic fluid - Inflammatory processes of the upper respiratory tract (thick and viscous bronchial secretions, difficulty coughing) Method of administration Tablets should be taken only on an empty stomach, i.e., 1 hour before meals. Adolescents: 2 tablets 3 times a day. After improvement, the dose can be reduced to 2 tablets 2 times a day. Chymoral enteric-coated tablets should not be used by individuals with allergies to the components. Chymoral enteric-coated tablets can only be taken after consulting a doctor. Chymoral enteric-coated tablets can be used during pregnancy, as well as during breastfeeding and in children under 12 years of age, only after consulting a doctor. Note: This dietary supplement is not intended to replace a varied and balanced diet. Special instructions: Do not exceed the recommended daily dose. Shelf life: 3 years Do not use after the expiry date indicated on the packaging. Packaging: Enteric-coated tablets, 30 tablets per pack. 11080 Belgrade, Batajnički drum, bb Storage: Store at a temperature up to 25°C, in the original packaging. Keep out of reach of children!